Concepedia

Secukinumab may be a valid treatment option in patients with CNS demyelination and concurrent ankylosing spondylitis: Report of two clinical cases

Antonio Cortese, Ramona Lucchetti, Alessio Altobelli, Antonella Conte, Marco Primavera, Guido Valesini, Enrico Millefiorini, Rossana Scrivo

Multiple Sclerosis and Related Disorders · 2019 · 22 citations · 7 references

DOI

Concepts

References

7

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

Chris H. Polman, Stephen C. Reingold, Brenda Banwell et al. · Annals of Neurology · 2011 · 9.8K citations · Full text

, , +10

Evaluation of Diagnostic Criteria for Ankylosing Spondylitis

Sjef van der Linden, Hans A. Valkenburg, A. Cats · Arthritis & Rheumatism · 1984 · 5.7K citations

, , +6

Activity of secukinumab, an anti-IL-17A antibody, on brain lesions in RRMS: results from a randomized, proof-of-concept study

Eva Havrdová, Anna N. Belova, Alla Goloborodko et al. · Journal of Neurology · 2016 · 225 citations

, , +13

Clustering of autoimmune diseases in families with a high-risk for multiple sclerosis: a descriptive study

Lisa F. Barcellos, Brinda B. Kamdar, Patricia P. Ramsay et al. · The Lancet Neurology · 2006 · 205 citations

, , +16

Comorbidities amongst patients with multiple sclerosis: a population‐based controlled study

Jiunn‐Horng Kang, Y.‐H. Chen, Hsin-Chuan Lin · European Journal of Neurology · 2010 · 127 citations

, , +17